Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

AstraZeneca ramps up COVID-19 vaccine accessibility with $1B in funding

Biopharmaceutical company AstraZeneca has received more than $1 billion in funding from BARDA for the development, production and delivery of Oxford University's vaccine for COVID-19.

Thumbnail

CMS issues plan to open up nursing homes

CMS has issued a plan to reopen the nation’s nursing homes with a new guidance for state and local officials.

Thumbnail

CVS Health to return $43M in coronavirus funds

CVS Health has stated it will return $43 million in funding it received for COVID-19 relief.

5G innovation lab opens to support AI development, edge computing, more

The lab’s leaders are pledging to support innovators in various industries—including healthcare—who will have a hand in the rise of 5G technology.

Thumbnail

Hospitals face steep revenue declines amid patient volume losses

Hospitals and healthcare providers are facing higher costs to care for complex COVID-19 patients while also suffering the loss of other procedures like elective surgeries that could help offset these higher costs.

Thumbnail

President Trump taking unproven drug to prevent COVID-19 infection

President Trump recently stated he was taking hydroxychloroquine, an anti-malaria drug that has been unproven to prevent or treat infection of COVID-19. Trump has touted the drug over the past several weeks for benefitting COVID-19 patients, but studies have shown little to no impact.

Thumbnail

10% of patients with a ‘big three’ disease are misdiagnosed

The most commonly missed condition seems to be spinal abscess, an infection that can cause paraplegia yet was fumbled in more than 62% of cases.

Thumbnail

Healthcare disrupter Haven recruiting replacement for Gawande

Just six months after Haven piloted its initial health-benefits plans, Atul Gawande, MD, MPH, is relinquishing his role as the fledgling organization’s CEO.

Displaying 1945 - 1952 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup